Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
In fiscal year 2022, Aurobindo Pharma spent around 0.31 billion Indian rupees on capital expenses for research and development of pharmaceutical drugs. Recurring expenses for R&D of the company were more than 8.66 billion rupees in the same year.
Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's ANDA filings FY 2019, by therapy
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
Selected statistics
1
Other regions
10
- Basic Statistic Americans' preferred pharma companies for drug purchase, by gender 2017
- Basic Statistic Dispensed thyroid medicines in the Netherlands 2014-2022
- Premium Statistic Distribution of expenditure on cancer drugs in Italy 2020, by type
- Premium Statistic Sales of pharmaceutical drugs Thailand 2021, by type
- Basic Statistic Revenue of pharmaceutical products manufacturing in the UK 2008-2021
- Premium Statistic Subsidized drug expenditure in Australia FY 2016-2022
- Premium Statistic Drug production value of cardiovascular agents Japan 2022, by category
- Premium Statistic Leading European pharmaceutical & biotechnology companies by market cap 2023
- Basic Statistic Worldwide top origins for pipeline drugs by number of active drugs 2024
- Premium Statistic Export value medical equipment Indonesia 2019-2022
Related statistics
10
- Premium Statistic India's public expenditure on health as a share of GDP FY 2010-2020
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
- Premium Statistic GSK Pharmaceuticals' net assets India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' India equity share capital FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
Further related statistics
9
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Further Content: You might find this interesting as well
Statistics
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Aurobindo Pharma. (July 12, 2022). Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees) ." Chart. July 12, 2022. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. (2022). Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees) . Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on Research and Development by Aurobindo Pharma Limited from Financial Year 2017 to 2022, by Type (in Billion Indian Rupees) ." Statista, Statista Inc., 12 Jul 2022, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma, Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees) Statista, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/ (last visited May 21, 2024)
Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees) [Graph], Aurobindo Pharma, July 12, 2022. [Online]. Available: https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/